Sante Quebec Centre Hospitalier De L'universite De Montreal

Montréal, QC Doing business as Chum, LE Research Center

UEI
GLYKCC2W6BN7
CAGE
L6460
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
  • Hospital
Entity structure
International Organization
SAM.gov registration date
Physical address
850 R. Saint-Denis, Montréal, QC H2X 0A9, Canada
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in… R01EY036865 National Eye Institute (NIH) $2,674,763
Retinal ganglion cell dendrite and synapse regeneration in glaucoma: the role of insulin signaling. R01EY030838 National Eye Institute (NIH) $5,288,923
A C9ORF72 pipeline for ALS drug discovery and treatment W81XWH1710080 Medical Command (Army) $466,007
Exploring the role of IL-32 as a potential biomarker and therapeutic target in premature cardio-vascular diseases… R01AG054324 National Institute on Aging (NIH) $6,813,565
The role of lifestyle factors in ovarian cancer prognosis W81XWH1510502 Department of Defense $232,688

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Massachusetts Medical School The objective of this proposal is to characterize at the molecular level HIV-1 Env open conformation susceptible to attack by commonly-elicited non-neutralizing… R01AI150322 $174,960
Emory University Correlates of protective immunity to HCV and rational vaccine design U19AI159819 $259,994
Vanderbilt University Medical Center Longitudinal Study of HIV and Aging in Brazil R01AG071439 $32,112
Yale Univ Dr. Finzi ( co-principal investigator) will dissect the different specificities of nnAbs, present in the plasma of a cohort of PLWH from Montreal, that… R01AI186809 $126,360
Van Andel Research Institute This subaward will encompass experiments towards understanding the regulation and role of beta cell heterogeneity, its regulation by the epigenome, and… R01DK139630 $152,010

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
The Sir Mortimer B. Davis-Jewish General Hospital UEI EMCNUAEK3UV3 Montréal, QC 622110 General Medical and Surgical Hospitals
The Research Institute Of The Mcgill University Health Centre UEI WSJTUAPBJMA4 Montreal, QC 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
ST Michael's Hospital UEI W2TKDMBKGQE5 Toronto, ON 622110 General Medical and Surgical Hospitals
CHU Sainte-Justine UEI FGEYHE97DQB5 Montréal, QC 622110 General Medical and Surgical Hospitals
Faculté D'Administration UEI N6JXEMKS39F4 Sherbrooke, QC 611310 Colleges, Universities, and Professional Schools

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Centre Hospitalier De L'Universite De Montreal (CHUM), operating as CHUM, LE, is an international non-profit hospital and research organization headquartered in Montreal, Quebec, Canada. Registered in SAM.gov since February 2007, CHUM serves as a research-focused medical institution providing advanced biomedical research services to the U.S. federal government. The organization leverages its clinical expertise and research infrastructure to conduct cutting-edge investigations addressing significant health challenges, positioning itself as a valuable collaborator in federally-funded research initiatives.

CHUM has demonstrated substantial engagement in federal research funding, serving as both a prime recipient and subrecipient on multiple grants primarily administered by the National Institutes of Health (NIH). As a prime awardee, CHUM received a three-year Project Grant from the National Eye Institute (CFDA 93.867 - Vision Research) for $2,674,763 beginning September 30, 2025, focused on investigating interpericyte tunneling nanotubes as therapeutic targets for glaucoma treatment and vision restoration. As a subrecipient, CHUM has contributed to numerous research initiatives spanning infectious disease, metabolic disorders, and vision restoration. Key research areas include HIV/AIDS studies involving HIV reservoir characterization, broadly neutralizing antibody development, and viral eradication strategies conducted with prime partners including Rockefeller University, Oregon Health & Science University, and Fred Hutchinson Cancer Center. The organization has also participated in hepatitis C virus (HCV) vaccine design research with Emory University, type 2 diabetes studies examining pancreatic beta cell function and fatty acid receptor signaling with University of California Davis and University of Michigan, and vision rehabilitation programs for ultra-low vision patients with The Research Foundation For The State University Of New York. Additional collaborative work includes optic nerve compression injury modeling with McGill University's Royal Institution and HIV-infected cell elimination research with the Henry M. Jackson Foundation, demonstrating CHUM's broad research portfolio spanning infectious disease, metabolic disease, and sensory rehabilitation sciences.

Quick answers

Is Sante Quebec Centre Hospitalier De L'universite De Montreal registered in SAM.gov?

Yes. Sante Quebec Centre Hospitalier De L'universite De Montreal's SAM.gov registration is active through August 24, 2027.

What is Sante Quebec Centre Hospitalier De L'universite De Montreal's CAGE code?

Sante Quebec Centre Hospitalier De L'universite De Montreal's CAGE code is L6460, and its Unique Entity ID (UEI) is GLYKCC2W6BN7.

What is Sante Quebec Centre Hospitalier De L'universite De Montreal's most recent federal award?

Sante Quebec Centre Hospitalier De L'universite De Montreal's most recent federal grant award is Interpericyte tunneling nanotubes as new therapeutic targets for neurovascular recovery and vision restoration in… (R01EY036865), from National Eye Institute (NIH), on September 30, 2025.

On GovTribe

See Sante Quebec Centre Hospitalier De L'universite De Montreal's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe